Sysmex Corp. (SSMXY)
11.83
-0.11
(-0.89%)
USD |
OTCM |
Oct 08, 16:00
Sysmex Enterprise Value : 7.224B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 7.224B |
| October 07, 2026 | 7.288B |
| October 06, 2026 | 7.273B |
| October 05, 2026 | 7.085B |
| October 02, 2026 | 7.043B |
| October 01, 2026 | 7.188B |
| September 30, 2026 | 7.127B |
| September 29, 2026 | 7.115B |
| September 28, 2026 | 7.273B |
| September 25, 2026 | 7.406B |
| September 24, 2026 | 7.133B |
| September 23, 2026 | 7.164B |
| September 22, 2026 | 7.218B |
| September 21, 2026 | 7.236B |
| September 18, 2026 | 7.212B |
| September 17, 2026 | 7.357B |
| September 16, 2026 | 7.346B |
| September 15, 2026 | 7.220B |
| September 14, 2026 | 7.170B |
| September 11, 2026 | 7.091B |
| September 10, 2026 | 6.993B |
| September 09, 2026 | 7.224B |
| September 08, 2026 | 7.279B |
| September 04, 2026 | 7.587B |
| September 03, 2026 | 7.605B |
| Date | Value |
|---|---|
| September 02, 2026 | 7.297B |
| September 01, 2026 | 7.406B |
| August 31, 2026 | 7.472B |
| August 28, 2026 | 7.424B |
| August 27, 2026 | 7.321B |
| August 26, 2026 | 7.400B |
| August 25, 2026 | 7.533B |
| August 24, 2026 | 7.460B |
| August 21, 2026 | 7.581B |
| August 20, 2026 | 7.279B |
| August 19, 2026 | 7.400B |
| August 18, 2026 | 7.200B |
| August 17, 2026 | 7.055B |
| August 14, 2026 | 7.315B |
| August 13, 2026 | 7.230B |
| August 12, 2026 | 7.430B |
| August 11, 2026 | 7.675B |
| August 10, 2026 | 7.617B |
| August 07, 2026 | 6.685B |
| August 06, 2026 | 6.298B |
| August 05, 2026 | 6.259B |
| August 04, 2026 | 6.219B |
| August 03, 2026 | 6.155B |
| July 31, 2026 | 6.098B |
| July 30, 2026 | 6.353B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 41.37B |
| Neogen Corp. | 3.158B |
| QuidelOrtho Corp. | 3.800B |
| Trinity Biotech Plc | 136.74M |
| Aspira Women's Health, Inc. | 14.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.07M |
| Revenue (Quarterly) | 820.03M |
| Total Expenses (Quarterly) | 765.49M |
| EPS Diluted (Quarterly) | 0.0889 |
| Gross Profit Margin (Quarterly) | 50.74% |
| Profit Margin (Quarterly) | 6.59% |
| Earnings Yield | 3.53% |
| Operating Earnings Yield | 6.11% |
| Normalized Earnings Yield | 4.228 |